To date, PARP inhibitors, including niraparib, rucaparib and olaparib have been approved by US-FDA to treat cancers, including prostate cancer, breast cancer and ovarian cancer, through disrupting DNA repair and replication pathways
Clinical Update 10/15/2021 How Coffee Helps the Heart A recent study may help explain how moderate coffee consumption reduces the risk of heart disease
Emerging applications of nanotechnology in healthcare and medicine
Furthermore, the apoptosis-inducing effect and mechanism of FOXO4-DRI in a serum limitation-induced senescent fibroblast and organ culture models of keloids were examined
Trends in Pharmacological Sciences
It is a tripeptidemeaning its made up of three essential amino acids: Cysteine: The key player, as it provides the sulfur atom crucial for its antioxidant activity